O-2 Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)
Titel:
O-2 Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)
Auteur:
Knox, J. Bazin, I. Oh, D. Zubkov, O. Breder, V. Bai, L. Christie, A. McNamara, M. Goyal, L. Cosgrove, D. Springfeld, C. Sjoquist, K. Park, J. Verdaguer, H. Braconi, C. Ross, P. de Gramont, A. Shroff, R. Zalcberg, J. Palmer, D. Valle, J.